Energy Drinks Consumption, Knowledge and Self-Reported Effect among University Students in Jordan: Cross-sectional Study
Abstract
Consumption of energy drinks (EDs) has increased exponentially among
younger generations, and this increase is projected to continue.
This study aimed to examine the prevalence, knowledge level, intake patterns, and
consumer experience of consuming EDs among university students in Jordan.
A cross-sectional study of 467 students from 29 universities was conducted by a webbased
questionnaire. Descriptive analyses, chi-square tests, and logistic regression were performed,
with a p-value of ≤0.05 indicating significance.
The prevalence of EDs was 40.1% among university students. Over half (62.7%) of students
had poor knowledge of EDs. The most significant determinants identified were male
(OR=2.18; 95%CI: 1.14-4.15), undergraduate (OR: 4.01; 95% CI: 1.70-9.72), in a nonmedical
discipline (OR=2.92; 95% CI: 1.56-5.44), smoker (OR=9.91;95%Cl: 5.30-18.54) and
having a poor knowledge level (OR=40.46;95%CI: 14.33-114.27). Students mainly consumed
Red Bull, and the majority consumed 1-2 can(s) daily. Students were more likely to consume
EDs during exams to mainly stay awake. The major side effects experienced by this sample were
increased urination and headache. No changes in mental or physical performance, weight, appetite,
and sleeping pattern were observed among the majority of respondents.
Consumption of EDs was moderate among university students. Gender, study
course, study year, smoking, and knowledge level were determinants of their intake.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.